Electra Therapeutics, Inc., a clinical stage biotechnology company developing antibody therapies against novel targets for immunological diseases and cancer, today announced that the U.S. Food and ...

I just look back and say, 'Thank God I made it through.' As a toddler in Cincinnati, Ohio, William was diagnosed with hemophagocytic lymphohistiocytosis, a rare, life-threatening disorder in which the ...

Electra Therapeutics, Inc., a clinical stage biotechnology company developing antibody therapies against novel targets for immunological diseases and cancer, today announced that the U.S. Food and ...

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

Outzen was recently diagnosed with HLH (Hemophagocytic lymphohistiocytosis), a severe, systemic inflammatory syndrome, ...

The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.

In the US, emapalumab-lzsg is indicated for pediatric (newborn and older) and adult primary hemophagocytic lymphohistiocytosis (HLH) patients with refractory, recurrent or progressive disease, or ...

Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.

including 30% that were Grade 1 or 2 and 17% that were Grade 3Rapid cytopenia recovery in the vast majority of casesNo ...

IEC-HS includes the preferred terms IEC-HS, HLH, Hemophagocytic lymphohistiocytosis, and atypical HLH. Two patients developed an inflammatory syndrome prior to the existence of IEC-HS as a term in ...

Hemophagocytic Lymphohistiocytosis (HLH)/Macrophage Activation Syndrome (MAS): In patients receiving ABECMA in the KarMMa and KarMMa-3 studies, HLH/MAS occurred in 2.9% (10/349) of patients.